(Q41226267)

28 September 2017

Effect of long-term normalization of serum complement levels on the course of lupus nephritis (English)

1 reference

28 September 2017

R S Laitman

1

1 reference

28 September 2017

D Glicklich

2

1 reference

28 September 2017

L B Sablay

3

1 reference

28 September 2017

A I Grayzel

4

1 reference

28 September 2017

P Barland

5

1 reference

28 September 2017

N Bank

6

1 reference

28 September 2017

language of work or name

English

0 references

publication date

1 August 1989

1 reference

American Journal of Medicine

28 September 2017

1 reference

28 September 2017

87

1 reference

28 September 2017

132-138

1 reference

28 September 2017

2

1 reference

The treatment of lupus nephritis

28 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980687-4

NIH conference. Lupus nephritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980687-4

Immune Complexes, Complement, and Anti-DNA in Exacerbations of Systemic Lupus Erythematosus (SLE)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980687-4

Significance of persisting serologic abnormalities in SLE

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980687-4

Serologically active clinically quiescent systemic lupus erythematosus: a discordance between clinical and serologic features

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980687-4

Systemic lupus erythematosus within the first two decades of life

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980687-4

STEROID THERAPY OF SYSTEMIC LUPUS ERYTHEMATOSUS BASED ON IMMUNOLOGIC CONSIDERATIONS

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980687-4

The effect of normalization of serum complement and anti-DNA antibody on the course of lupus nephritis: a two year prospective study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980687-4

The effect of continuous normalization of serum hemolytic complement on the course of lupus nephritis: a five year prospective study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980687-4

Diffuse proliferative lupus nephritis: identification of specific pathologic features affecting renal outcome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980687-4

Effect of treatment on the evolution of renal abnormalities in lupus nephritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980687-4

Therapy of lupus nephritis. Controlled trial of prednisone and cytotoxic drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980687-4

Chronic glomerulonephritis: nonimmunologic mechanisms of progressive glomerular damage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980687-4

10.1016/S0002-9343(89)80687-4

7 January 2021

Identifiers

DOI

1 reference

28 September 2017

1 reference